تحت رعاية سموّ الشيخ خالد بن محمد بن زايد آل نهيان، ولي عهد أبوظبي رئيس المجلس التنفيذي لإمارة أبوظبي
Under the Patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of Abu Dhabi Executive Council

HealthBeats Podcast

Accelerating the Future of Healthcare Together with your host Lara Setrakian

img 12 July 2024

Genomic Insights, Personalised Solutions: Redefining Pediatric Cancer Care

In this thought-provoking podcast episode, we dive into the transformative potential of routine whole genome sequencing in revolutionizing the diagnosis and treatment of pediatric cancers. Join us as we explore the cutting-edge advancements in genomics that are empowering clinicians to provide truly personalised and molecularly informed care for children battling this formidable disease. Through engaging discussions with a leading expert in the field, we unravel the remarkable journey of implementing whole genome sequencing as a standard practice, shedding light on its profound impact on clinical decision-making and patient outcomes. Prepare to be inspired by the stories of hope and resilience that emerge from this groundbreaking approach, as we navigate the challenges and celebrate the triumphs of harnessing the power of genomics to transform the lives of the youngest and most vulnerable among us.
MEET THE SPEAKER

Paediatric Haematologist

Dr. Jack Bartram

Paediatric Haematologist

Great Ormond Street Hospital for Children

Dr Jack Bartram is a Consultant Paediatric Haematologist, Speciality Lead and the Clinical Director of the Specialised Integrated Haematology Malignancy Diagnostic Service at Great Ormond Street Hospital for Children (GOSH), London, UK. Nationally he is the Clinical Lead for infant leukaemia and minimal residual disease (MRD) in acute lymphoblastic leukaemia (ALL) network. He undertook a PhD at UCL Institute of Child Health, then a leukaemia research fellowship in the Genomic Medicine Programme at The Hospital for Sick Children “SickKids” in Toronto. Dr Bartram leads on molecular diagnostics within the Haematology Department at GOSH and has extensive expertise in high throughput sequencing for MRD analysis and was responsible for implementation of advanced genomic diagnostics and whole genome sequencing as standard of care for children with cancer at GOSH.

His research interest involves using advanced molecular diagnostic techniques to predict outcomes and find targets for novel therapies for children with haematological malignancies. Dr Bartram is co-principal investigator for CRUK funded REVEALL (RElapse-specific therapeutic Vulnerability Evaluation in childhood & young adult Acute Lymphoblastic Leukaemia) study and co-principal investigator on SAIL (Scientific Advances in Infant Leukaemia) study. He is currently the Clinical Lead for Haematological Malignancy Genomics in the NHSE North London Genomic Laboratory Hub and has been responsible for the implementation of advanced genomics and whole genome sequencing into clinical practice at GOSH.

img 05 July 2024

The Intersection of Health and Climate: An Urgent Global Priority

The health of our planet and the health of its inhabitants are inextricably linked. Climate change poses a significant threat to human health, exacerbating existing health challenges and creating new ones. In this thought-provoking podcast, we delve into the critical intersection of health and climate. Our guest, an esteemed leader in the pharmaceutical industry, will share insights on how climate change impacts global health, the role of the healthcare sector in mitigating climate risks, and the urgent need for collective action to address this pressing global issue. Join us for a compelling discussion that explores the intersection of two of the most pressing challenges of our time.
MEET THE SPEAKER

Sameh El Fangary, Cluster President, GCC & Pakistan, AstraZeneca

Sameh El Fangary

Country President – GCC Cluster

AstraZeneca

Sameh El Fangary joined AstraZeneca in December 2020, bringing with him a wealth of experience in the pharmaceutical industry spanning 25 years. As a pharmacist holding a Master's in Business Administration, Sameh has held numerous roles across GCC and the UK gaining valuable expertise across a broad spectrum of disease areas including Primary Care, Specialties, Oncology, Rare Diseases, and Vaccines.

Inspired by AstraZeneca’s commitment to Science, Innovation, and Sustainability, and serving as the co-chair of the PHRMAG trade association, Sameh has played a pivotal role in fostering industry collaboration with both government and private sectors. His efforts have contributed significantly to transforming patient outcomes and advancing the global and regional agenda for the health of people, society, and the planet.

img 20 June 2024

How Public and Private Partnerships are Shaping the Future of Healthcare in the UAE

In this podcast episode, join Ashraf Mallak, the Managing Director at MSD GCC, as he delves into the heart of healthcare innovation in the UAE. Through pioneering public-private partnerships, the UAE has transformed its healthcare landscape, focusing on telemedicine, data-driven breakthroughs, and a patient-centric approach. Ashraf takes you on a journey exploring the captivating realm of healthcare innovation, from the gleaming skylines of Dubai to the global stage. Discover the visionary collaborations that are shaping the healthcare landscape of tomorrow, and gain an in-depth understanding of the transformative revolution in healthcare that is taking place.
MEET THE SPEAKER

Managing Director, MSD GCC

Ashraf Mallak

Managing Director

MSD GCC

Ashraf Mallak is the Managing Director for MSD GCC. He has been recognized by Forbes Middle East as one of top 50 healthcare leaders in 2023 and 2022.

He is a member of the Executive Committee of The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG) and serves on the Board of Directors of the American Chamber of Dubai (AmCham).

Ashraf’s innate commercial and operational capabilities have helped MSD in the GCC to develop an outstanding commercial strategy utilizing digital data and analytics to make effective business decisions that benefit the company and its stakeholders.

Prior to his role as MD for the GCC, Ashraf served as Managing Director for KSA where he led the transformation of the business in the market. Under his leadership, the business in Saudi Arabia grew by 110%. He also led EEMEA regional commercial operations where he worked closely with markets and the global center of excellence at MSD to drive the execution of the company’s data and analytics capabilities as well as the deployment of a rapid response automated tool across EEMEA markets.

Ashraf joined MSD in 2002 and held several local and regional roles across sales, marketing, market access, business unit management, commercial and operations and general management.

img 14 June 2024

Pioneering Patient-Centric Healthcare Solutions

In this podcast episode, join Pedro Matias Rosa, the Managing director of Johnson and Johnson GULF. In a world where medical needs evolve rapidly, we are at the forefront of healthcare innovation, pioneering patient-centric solutions that redefine possibilities. Our unwavering focus on critical areas like oncology, immunology, and neuroscience fuels our relentless pursuit of breakthroughs that transform lives. We don't just develop treatments; we forge a deeper understanding of individual patient experiences, shaping our scientific endeavors to enhance outcomes and elevate the standard of care.
MEET THE SPEAKER

Managing director, Johnson and Johnson GULF

Pedro Matias Rosa

Managing director

Johnson and Johnson GULF

The Future of Digital Health Isn't Digital - It's Human. Unlocking the Power of Hybrid Healthcare

Check out this sneak peek as we sit down with Ali Hashemi, CEO and founder of meta[bolic], to discuss the future of digital health and why he believes it will be defined by hybrid models that blend virtual and in-person care. Hashemi shares his vision for human-centered digital health tools that empower patients and providers, not replace them. We explore the potential of hybrid healthcare to improve outcomes, lower costs, and restore the human element to medicine.